Fmoc-Arg(Me)2-OH (symmetrical)

Fmoc-Arg(Me)2-OH (symmetrical) is an Fmoc-protected arginine derivative in which the guanidinium side chain is masked as a symmetrical dimethylguanidine motif, preserving the amino acid backbone stereochemistry while tuning side-chain basicity and nucleophilicity. The molecule contains an Fmoc carbamate on the alpha-amino group, a free carboxylic acid for coupling chemistry, and a substituted guanidine functionality that can participate in salt formation, hydrogen bonding, and controlled deprotonation behavior during peptide assembly. The dimethylguanidine pattern can reduce the propensity for strong cation-anion interactions relative to unprotected arginine, which may influence solubility and side-chain reactivity under synthesis conditions. As a chiral, protected amino acid building block, it functions as a defined intermediate for peptide coupling, side-chain engineering, and downstream guanidine-related transformations in both research and industrial fine chemical workflows.

1. Peptide Synthesis

Fmoc-Arg(Me)2-OH (symmetrical) is used in peptide synthesis where the Fmoc-protected alpha-amino group enables standard base-mediated deprotection followed by amide bond formation at the C-terminus. The free carboxylic acid supports peptide coupling strategies compatible with automated peptide synthesizers, while the dimethylguanidine side chain provides a protected arginine-like functionality that can be carried through assembly with reduced side reactions compared with more strongly basic guanidinium forms. The symmetrical N,N-dimethyl substitution pattern supports consistent steric and electronic behavior during coupling and purification, aiding reproducible incorporation of arginine analog residues. The resulting peptides and peptide fragments can serve as substrates for further side-chain modification or as defined scaffolds for studying guanidinium-dependent recognition.

2. Protected Amino Acids

Fmoc-Arg(Me)2-OH (symmetrical) functions as a protected amino acid derivative for synthetic planning in which orthogonality between the Fmoc group and side-chain chemistry is required. The Fmoc carbamate masks the alpha-amine during iterative coupling cycles, while the carboxylic acid remains available for activation and coupling to the next residue. The dimethylguanidine side chain can be treated as a masked guanidine equivalent, enabling controlled exposure of guanidine-like hydrogen-bonding motifs after peptide assembly or during post-synthetic derivatization. Downstream deprotection or functional conversion steps can be applied to generate guanidine-bearing analogs, supporting amino acid derivatization workflows and peptide analog construction.

3. Chemical Biology Conjugation

Fmoc-Arg(Me)2-OH (symmetrical) can be applied in chemical biology and biomolecule modification workflows that require guanidinium-like charge distribution for molecular recognition. The amino acid backbone provides a defined attachment point for incorporation into peptides, while the dimethylguanidine side chain contributes to cationic character and multidentate hydrogen bonding that can influence binding to nucleic acids, glycans, or protein surfaces in assay contexts. The Fmoc protection strategy allows the residue to be assembled into conjugation-ready peptides or peptidomimetic linkers with controlled stereochemistry and sequence-defined positioning. The prepared conjugation constructs may then be used to generate labeled or functionalized biomolecular probes for mechanistic studies and structure-function investigations.

4. Peptidomimetics And SAR Studies

Fmoc-Arg(Me)2-OH (symmetrical) is suitable for peptidomimetic construction and structure-activity relationship studies where arginine side-chain geometry and charge patterning are tuned. The symmetrical dimethylguanidine group provides a defined guanidine analog that can modulate basicity, solvation, and electrostatic interactions relative to canonical arginine, enabling systematic variation of side-chain properties in peptide analog libraries. The Fmoc-protected backbone supports incorporation into constrained sequences and fragment-based designs that maintain stereochemical fidelity at the alpha-carbon. Downstream, the resulting analogs can be employed as defined chemical matter for SAR mapping, affinity profiling, and mechanistic comparison of guanidinium-dependent binding motifs.

5. Process Chemistry Intermediate

Fmoc-Arg(Me)2-OH (symmetrical) serves as a chiral amino acid intermediate in process chemistry and specialty chemical production where reproducible protection-group behavior is required for scalable peptide building block manufacture. The Fmoc group and carboxylic acid functionality provide clear handles for activation, purification, and controlled deprotection cycles, supporting manufacturing route design for protected amino acid synthesis and peptide-grade intermediate preparation. The dimethylguanidine side chain can be managed as a stable, isolable functionality during upstream steps, while still enabling downstream conversion into guanidine-bearing derivatives after peptide assembly or targeted transformations. The compound's defined stereochemistry and orthogonal protection scheme make it compatible with industrial fine chemical synthesis of peptide intermediates and related functional molecules.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma